Resources | NITAG RESOURCE CENTER

2024 ∙ STIKO

Resolution on the STIKO recommendation for a standard vaccination against diseases caused by respiratory syncytial viruses (RSV) for persons ≥ 75 years of age and for the indication vaccination of persons aged 60 to 74 years with risk factors

2024 ∙ STIKO

Modelling methods for predicting epidemiological and health economic effects of vaccinations. Guidance for analyses to be presented to the German Standing Committee on Vaccination (STIKO)

2024 ∙ JCVI

JCVI Horizon Scanning sub-committee - Minute of the meeting held on 05 January 2024

2024 ∙ STIKO

The STIKO recommendation on vaccination against dengue with the Qdenga vaccine

2024 ∙ JCVI

JCVI statement on COVID-19 vaccination in spring 2024 and considerations on future COVID-19 vaccination

2023 ∙ Lanza, T. E. Lombardi, G. S. Tumelero, S. Paladini, A. Castagna, C. Cadeddu, C.

Barriers and strength factors of adult immunization plans in seven countries of the European region

2023 ∙ Elhassan, Yasir S. Iqbal, Fizzah Arlt, Wiebke Baldeweg, Stephanie E. Levy, Miles Stewart, Paul M. Wass, John Pavord, Sue Aled Rees, D. Ronchi, Cristina L.

2023 ∙ Murali, Mayur Gumber, Leher Jethwa, Hannah Ganesh, Divolka Hartmann-Boyce, Jamie Sood, Harpreet Zaccardi, Francesco Khunti, Kamlesh

Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis

2023 ∙ STIKO

Decision on the implementation of the COVID-19 vaccination into the general recommendations of the STIKO 2023

2023 ∙ JCVI

JCVI statement on a childhood varicella (chickenpox) vaccination programme